Boon Logic

Name: Boon Logic
Brand: Boon Logic
Rating: 4.3 (2 reviews)

Unsupervised machine learning delivering cutting-edge anomaly detection for predictive maintenance and quality control.

Est 2018|Valuation $48M|Raised $11M|6 Ref Customers

LinkedIn 1K|Website|FTEs 19|HQ Minneapolis, Minnesota, US

MarketsPlant Maintenance

01Competitive Landscape

Narrative analysis

Where Boon Logic's approach may be advantageous: - An unsupervised, normal-operation modelling approach can be appropriate when failures are rare and labeled failure datasets are unavailable. - The vendor emphasizes computation on commodity CPUs and edge-capable deployment, which may be relevant for constrained environments. - Partner integrations (for example, IIoT platform references) indicate positioning to fit into IIoT pipelines. Where alternatives often have advantages: - Augury: broader independent coverage and a bundled offering (sensors + diagnostics + services). - Cognex/Keyence: widely deployed machine-vision hardware and established integrator ecosystems. - Landing AI: a self-serve entry model and more visible security/compliance messaging. Market adoption signals (limited): - Public review volume for the vendor on major review sites is low. - Partnership announcements demonstrate integration interest but are mainly press-release-driven; independent adoption metrics are not publicly available.

	Boon Logic (Amber/AVIS)	Augury (PdM)	Landing AI (Vision AI)
Starting Price	Not publicly listed (sales-led engagement)	Not publicly listed (sales-led engagement)	Free tier available; enterprise pricing requires contact with sales
Best For	Organizations evaluating unsupervised anomaly detection trained on normal operation; edge/low-compute contexts; specific pharma inspection scenarios	Plants seeking a sensor+AI+service PdM program with diagnostic services	Teams seeking a general-purpose visual AI platform with self-serve entry and cloud tooling
Key Strength	Vendor-stated rapid training and normal-operation modelling; partner integrations with IIoT platforms	Established market presence with sensor+service offerings and broader coverage	More visible pricing entry points and broader developer ecosystem; public security/compliance messaging
Key Weakness	Limited independent reviews and community footprint; public security/compliance documentation not explicit; pricing opaque	Program scale and cost may be higher for some buyers	Not specifically tailored to pharma inspection out of the box; edge/offline deployment is enterprise-focused

01Competitive Landscape

Narrative analysis

Where Boon Logic's approach may be advantageous:

An unsupervised, normal-operation modelling approach can be appropriate when failures are rare and labeled failure datasets are unavailable.
The vendor emphasizes computation on commodity CPUs and edge-capable deployment, which may be relevant for constrained environments.
Partner integrations (for example, IIoT platform references) indicate positioning to fit into IIoT pipelines.

Where alternatives often have advantages:

Augury: broader independent coverage and a bundled offering (sensors + diagnostics + services).
Cognex/Keyence: widely deployed machine-vision hardware and established integrator ecosystems.
Landing AI: a self-serve entry model and more visible security/compliance messaging.

Market adoption signals (limited):

Public review volume for the vendor on major review sites is low.
Partnership announcements demonstrate integration interest but are mainly press-release-driven; independent adoption metrics are not publicly available.

	Boon Logic (Amber/AVIS)	Augury (PdM)	Landing AI (Vision AI)
Starting Price	Not publicly listed (sales-led engagement)	Not publicly listed (sales-led engagement)	Free tier available; enterprise pricing requires contact with sales
Best For	Organizations evaluating unsupervised anomaly detection trained on normal operation; edge/low-compute contexts; specific pharma inspection scenarios	Plants seeking a sensor+AI+service PdM program with diagnostic services	Teams seeking a general-purpose visual AI platform with self-serve entry and cloud tooling
Key Strength	Vendor-stated rapid training and normal-operation modelling; partner integrations with IIoT platforms	Established market presence with sensor+service offerings and broader coverage	More visible pricing entry points and broader developer ecosystem; public security/compliance messaging
Key Weakness	Limited independent reviews and community footprint; public security/compliance documentation not explicit; pricing opaque	Program scale and cost may be higher for some buyers	Not specifically tailored to pharma inspection out of the box; edge/offline deployment is enterprise-focused